Company registration number 07897049 (England and Wales)
LABORATORY PERFUMES LTD
ABRIDGED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
LABORATORY PERFUMES LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
LABORATORY PERFUMES LTD
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
3
2,696
2,667
Investments
4
8,744
8,744
11,440
11,411
Current assets
Stocks
65,353
69,308
Debtors
5
170,001
163,040
Cash at bank and in hand
99,602
136,276
334,956
368,624
Creditors: amounts falling due within one year
6
(97,204)
(83,727)
Net current assets
237,752
284,897
Net assets
249,192
296,308
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
249,092
296,208
Total equity
249,192
296,308

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 10 April 2026 and are signed on its behalf by:
H Firth
Director
Company registration number 07897049 (England and Wales)
LABORATORY PERFUMES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

LABORATORY PERFUMES LTD is a private company limited by shares incorporated in England and Wales. The registered office is Balfour House, 741 High Road, Finchley, London, N12 0BP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
33.33% reducing balance
Computer equipment
33.33% reducing balance
1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme, Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

LABORATORY PERFUMES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
4
3
Tangible fixed assets
Fixtures, fittings & equipment
Computer equipment
Total
£
£
£
Cost
At 1 January 2025
1,977
10,017
11,994
Additions
-
0
999
999
At 31 December 2025
1,977
11,016
12,993
Depreciation and impairment
At 1 January 2025
1,697
7,630
9,327
Depreciation charged in the year
93
877
970
At 31 December 2025
1,790
8,507
10,297
Carrying amount
At 31 December 2025
187
2,509
2,696
At 31 December 2024
280
2,387
2,667
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
8,744
8,744
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
143,552
135,670
Other debtors
22,418
23,435
Prepayments
4,031
3,935
170,001
163,040
LABORATORY PERFUMES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
15,376
1,270
Taxation and social security
76,222
75,183
Other creditors
3,206
4,540
Accruals
2,400
2,734
97,204
83,727
2025-12-31 2025-01-01 false false false 10 April 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Aaron Firth Fiona Firth I Cosgrave H Firth 07897049 2025-01-01 2025-12-31 07897049 2025-12-31 07897049 2024-12-31 07897049 core:FurnitureFittings 2025-12-31 07897049 core:ComputerEquipment 2025-12-31 07897049 core:FurnitureFittings 2024-12-31 07897049 core:ComputerEquipment 2024-12-31 07897049 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 07897049 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07897049 core:CurrentFinancialInstruments 2025-12-31 07897049 core:CurrentFinancialInstruments 2024-12-31 07897049 core:ShareCapital 2025-12-31 07897049 core:ShareCapital 2024-12-31 07897049 core:RetainedEarningsAccumulatedLosses 2025-12-31 07897049 core:RetainedEarningsAccumulatedLosses 2024-12-31 07897049 bus:Director4 2025-01-01 2025-12-31 07897049 core:FurnitureFittings 2025-01-01 2025-12-31 07897049 core:ComputerEquipment 2025-01-01 2025-12-31 07897049 core:FurnitureFittings 2024-12-31 07897049 core:ComputerEquipment 2024-12-31 07897049 2024-12-31 07897049 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07897049 bus:FRS102 2025-01-01 2025-12-31 07897049 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 07897049 bus:Director1 2025-01-01 2025-12-31 07897049 bus:Director2 2025-01-01 2025-12-31 07897049 bus:Director3 2025-01-01 2025-12-31 07897049 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07897049 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP